A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus

PHASE2CompletedINTERVENTIONAL
Enrollment

346

Participants

Timeline

Start Date

October 24, 2023

Primary Completion Date

June 27, 2025

Study Completion Date

June 27, 2025

Conditions
Respiratory Syncytial Virus
Interventions
BIOLOGICAL

mRNA-1345

Sterile liquid for injection

BIOLOGICAL

Placebo

0.9% sodium chloride (normal saline) injection

Trial Locations (50)

13905

Velocity Clinical Research-Binghamton, Binghamton

14620

University of Rochester Medical Center (URMC) - Golisano Children's Hospital (GCH), Rochester

19107

DM Clinical Research - Philadelphia, Philadelphia

22003

PI-Coor Clinical Research, LLC, Annandale

23226

Clinical Research Partners, Richmond

23294

National Clinical Research, Inc., Richmond

29414

Coastal Pediatric Research, Charleston

29680

Tribe Clinical Research, Simpsonville

30214

Javara, Inc., Fayetteville

31210

Velocity Clinical Research-Primary Pediatrics, Macon, Macon

31405

CenExel iResearch, LLC, Savannah

32501

SEC Clinical Research, Pensacola

32829

Accel Research Sites - Nona Pediatric Center, Orlando

33122

D&amp;H Doral Research Center, LLC, Doral

33125

Med-Care Research, Miami

33321

D&H Tamarac Research Center, Tamarac

33777

Accel Clinical, Largo

34741

Kissimmee Clinical Research, Kissimmee

39503

Velocity Clinical Research, Gulfport, Gulfport

44121

Senders Pediatrics, South Euclid

48075

Great Lakes Research Institute, Southfield

55402

Clinical Research Institute, Minneapolis

66210

Velocity Clinical Research-Kansas City, Overland Park

67042

Alliance for Multispeciality Research, LLC, El Dorado

70006

Velocity Clinical Research Metairie, Metairie

70508

Velocity Clinical Research - Lafayette, Lafayette

75024

Village Pediatrics, Plano

76401

Javara Inc/Texas Health Care, PLLC d/b/a/ Privia Medical Group-North Texas, Stephenville

77055

West Houston Clinical Research Service, Houston

77065

DM Clinical Research - CyFair, Houston

77384

Javara Inc (Conroe), Conroe

77701

REX Clinical Trials, LLC, Beaumont

77901

Victoria Clinical Research Group, Victoria

78704

Elligo Clinical Research Center, Austin

83404

Clinical Research Prime, Idaho Falls

83642

Velocity Clinical Research - Boise, Meridian

84088

Velocity Clinical Research - Salt Lake City, West Jordan

85006

Velocity Clinical Research, Phoenix, Phoenix

85260

Headlands Research - Scottsdale, Scottsdale

87107

Velocity Clinical Research- Albuquerque, Albuquerque

90274

Peninsula Research Associates (PRA), Rolling Hills Estates

90815

Ark Clinical Research, Long Beach

92220

Velocity Clinical Research - Banning, Banning

92835

ASCADA Research, LLC - Family Medicine, Fullerton

48195-1896

Pediatric &amp; Adolescent Center, Southgate

19104-4318

The Children's Hospital of Philadelphia - Pediatrics, Philadelphia

02886

Velocity Clinical Research - Providence, Providence

07066

CEVAXIN Chorrera, La Chorrera

07093

CEVAXIN Avenida Mexico, Panama City

07114

CEVAXIN 24 de Diciembre, Panama City

All Listed Sponsors
lead

ModernaTX, Inc.

INDUSTRY

NCT06097299 - A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus | Biotech Hunter | Biotech Hunter